- Home
- GLOB vs ASND Comparison
GLOB vs ASND Comparison
Compare GLOB & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLOB
- ASND
- Stock Information
- Founded
- GLOB 2003
- ASND 2006
- Country
- GLOB Luxembourg
- ASND Denmark
- Employees
- GLOB N/A
- ASND N/A
- Industry
- GLOB EDP Services
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- GLOB Technology
- ASND Health Care
- Exchange
- GLOB Nasdaq
- ASND Nasdaq
- Market Cap
- GLOB 4.7B
- ASND 10.6B
- IPO Year
- GLOB 2014
- ASND 2015
- Fundamental
- Price
- GLOB $85.79
- ASND $175.45
- Analyst Decision
- GLOB Buy
- ASND Strong Buy
- Analyst Count
- GLOB 16
- ASND 17
- Target Price
- GLOB $174.94
- ASND $222.18
- AVG Volume (30 Days)
- GLOB 1.1M
- ASND 428.9K
- Earning Date
- GLOB 08-14-2025
- ASND 09-02-2025
- Dividend Yield
- GLOB N/A
- ASND N/A
- EPS Growth
- GLOB N/A
- ASND N/A
- EPS
- GLOB 3.38
- ASND N/A
- Revenue
- GLOB $2,455,696,000.00
- ASND $398,509,511.00
- Revenue This Year
- GLOB $4.36
- ASND $77.19
- Revenue Next Year
- GLOB $6.03
- ASND $75.84
- P/E Ratio
- GLOB $25.89
- ASND N/A
- Revenue Growth
- GLOB 11.90
- ASND 12.06
- 52 Week Low
- GLOB $85.00
- ASND $111.09
- 52 Week High
- GLOB $238.32
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- GLOB 34.50
- ASND 54.14
- Support Level
- GLOB $89.74
- ASND $168.01
- Resistance Level
- GLOB $95.26
- ASND $180.00
- Average True Range (ATR)
- GLOB 3.08
- ASND 6.12
- MACD
- GLOB 0.37
- ASND -0.28
- Stochastic Oscillator
- GLOB 2.97
- ASND 59.33
About GLOB Globant S.A.
Globant is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2003 in Argentina but is currently headquartered in Luxembourg and primarily serves clients in the US and Latin America. Globant's client base is relatively concentrated in the media and entertainment and financial services industries.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.